Literature DB >> 9039062

Reference-based pricing of prescription drugs.

P R McLaughlin.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9039062

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN： 0828-282X            Impact factor:   5.223


× No keyword cloud information.
  4 in total

Review 1.  Reference-based pricing schemes: effect on pharmaceutical expenditure, resource utilisation and health outcomes.

Authors:  Lisa L Ioannides-Demos; Joseph E Ibrahim; John J McNeil
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

2.  Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization.

Authors:  Sebastian Schneeweiss; Stephen B Soumerai; Robert J Glynn; Malcolm Maclure; Colin Dormuth; Alexander M Walker
Journal:  CMAJ       Date:  2002-03-19       Impact factor: 8.262

3.  Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors.

Authors:  C Bourgault; E Elstein; J Le Lorier; S Suissa
Journal:  CMAJ       Date:  1999-08-10       Impact factor: 8.262

Review 4.  Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.

Authors:  Angela Acosta; Agustín Ciapponi; Morten Aaserud; Valeria Vietto; Astrid Austvoll-Dahlgren; Jan Peter Kösters; Claudia Vacca; Manuel Machado; Diana Hazbeydy Diaz Ayala; Andrew D Oxman
Journal:  Cochrane Database Syst Rev       Date:  2014-10-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.